The main purpose of this study was to assess the prognosis and safety of HIPEC combined with PD-1 inhibitor and systemic chemotherapy in the first-line treatment of advanced GC patients with PM and to explore the factors affecting patients’ prognosis. Here, PDCD1 is linked to gastric cancer.